3B BlackBio DX opened lower at ₹1,590.10, compared with its previous close of ₹1,609.40. During today's session, the stock has traded between ₹1,499.40 and ₹1,631.90, with an average traded price of ₹1,544.20. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 1 year ago in 3B BlackBio DX is now worth
₹ 11,672.00
giving a profit of
₹ 1,672.00 (16.72%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-89.80 (-5.58%)
Day High
₹1,631.90
Day Low
₹1,499.40
Day Open
₹1,590.10
Prev Close
₹1,609.40
Volume
25,584
Value Traded
₹3.95 Cr
1W Return
-6.47%
1M Return
7.02%
3M Return
32.30%
6M Return
16.72%
1Y Return
16.72%
Market Cap (₹ Cr.)
1,304
PE Ratio
24.60
PB Ratio
4.27
Dividend Yield
0.31%
ROE
17.60%
ROCE
23.13%
Book Value (₹)
377.96
Face Value (₹)
10.00
EPS (TTM)
10.48
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-6.47%
6 Week
-
1 Month
7.02%
3 Month
32.30%
9 Month
16.72%
3B BlackBio Dx shareholders approve FY26 results and ₹5 dividend
Consolidated profit after tax stood at ₹59.92 crore for FY26. Final dividend of ₹5.00 per equity share recommended and approved. UK subsidiary sales grew 36% YoY to £1.75 million. Mithla Dubey re-appointed as director with 96.79% votes in favour.
13 days ago3B BlackBio Dx concludes Q1-FY27 review meeting with Marcellus
3B BlackBio Dx held a one-on-one meeting with Marcellus Investment Managers. The session took place on September 16, 2026, from 11:00 am to 12:00 pm. Management discussed Q1-FY27 results using previously disclosed materials. No unpublished price-sensitive information was shared during the call.
27 days ago3B BlackBio Dx concludes investor meeting with Capri Global Holdings
3B BlackBio Dx concluded one-on-one investor call with Capri Global Holdings. Meeting held on September 11, 2026, from 11:00 am to 12:00 pm India Time. Company reiterated Q1-FY27 investor presentation details during the session. No unpublished price-sensitive information was shared with the investor.
1mo ago3B BlackBio Dx sets AGM for Sept 29; declares ₹5 dividend
3B BlackBio Dx schedules 54th AGM for September 29, 2026. Final dividend of ₹5 per equity share declared for FY26. E-voting window open from September 26 to September 28, 2026. Annual Report accessible via company website for non-email registered holders.
1mo ago3B BlackBio Dx concludes investor meeting with Param Capital on Aug 29
3B BlackBio Dx completed its one-on-one meeting with Param Capital on August 29, 2026. The session lasted one hour, running from 1:00 pm to 2:00 pm India Time. Discussions centered on Q1-FY27 financial results and the associated investor presentation. The company confirmed no unpublished price-sensitive information was shared during the call.
1mo ago3B BlackBio Dx standalone PAT up 13% in Q1FY27 to ₹141.1 crore
3B BlackBio Dx Limited posted a 13% YoY rise in standalone net profit to ₹141.1 crore for Q1FY27, driven by higher other income. Consolidated PAT fell 29% to ₹89.8 crore as total income declined to ₹396.3 crore. The diagnostic kits segment contributed 96% of consolidated revenue.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,910.60 | -3.00% | ₹32,069.20 | 60.51 | +23.39% | |
| ₹1,406.50 | -3.14% | ₹14,486.63 | 79.85 | +43.37% | |
| ₹534.75 | -0.71% | ₹11,090.05 | 54.95 | +7.22% | |
| ₹499.45 | -3.00% | ₹7,949.51 | 46.60 | +18.54% | |
| ₹620.95 | +0.23% | ₹6,244.21 | 73.19 | +31.77% | |
| ₹532.70 | +0.05% | ₹1,728.01 | 17.74 | -35.43% | |
| ₹314.40 | +1.88% | ₹1,637.42 | 45.94 | +7.80% | |
| ₹549.85 | +0.95% | ₹1,074.57 | 14.50 | -2.73% | |
| ₹283.00 | -0.35% | ₹900.24 | -34.71 | -8.71% | |
| ₹105.19 | -0.40% | ₹765.65 | 33.11 | +31.06% | |
| ₹232.55 | +0.24% | ₹568.63 | 22.52 | -19.25% | |
| ₹64.50 | +0.00% | ₹81.09 | 16.62 | -33.30% |
An investment of ₹10,000 made 1 year ago in 3B BlackBio DX is now worth
₹ 11,672.00
giving a profit of
₹ 1,672.00 (16.72%)
Note: Past profits do not guarantee future returns.
